Corticosteroid + long-acting beta-2 agonist (LABA). Allow approx. 12hrs between doses. Asthma: ≥12yrs: initially 1 inh of 100/50 or 250/50 or 500/50 twice daily, based on disease severity and ...
Corticosteroid + long-acting beta-2 agonist (LABA). Allow approx. 12hrs between doses. Asthma: ≥12yrs: initially 1 inh of 100/50 or 250/50 or 500/50 twice daily, based on disease severity and ...
Novartis’ generics division said the regulator has accepted Sandoz’s filing for a generic of Advair Diskus, known as Seretide in Europe. If approved, the product will treat asthma in patients ...
Introduction: The incidence of asthma exacerbations in patients receiving salmeterol/fluticasone propionate (Seretideâ„¢ or Advair ®) is ... twice daily from a Diskusâ„¢ inhaler for a 4-week ...
Advair Diskus, by an average of 50%. GSK's new price cap applies to both of those products and the rest of its asthma and ...
The main patent on Advair (fluticasone+salmeterol) expired as long ago as 2010, while the patent on GSK’s Diskus inhaler expired ... twice daily treatment of asthma in patients age four and ...
Therefore, in patients with mild-to-moderate asthma, symptomatic on existing therapy, the salmeterol/FP combination is an effective alternative to increasing the dose of inhaled corticosteroids ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback